InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Sloan Sheldon. Officer active across 1 company, notably Spyre Therapeutics, Inc.. Cumulatively, 10 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €5.1m. Activity tracked since 1 April 2026. The latest transaction was filed on 1 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Sloan Sheldon is a declarant linked to Spyre Therapeutics, Inc., where the listed role is Chief Medical Officer. The record shows 10 filings in total, and across the 10 sampled filings from 2026-04-03 to 2026-05-01, the transactions are all sales, for total sell volume of EUR 5118342.